PRESS RELEASE published on 12/09/2025 at 14:50, 9 months 6 days ago Inside Information / Other news releases Teva Pharmaceuticals submits NDA to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749 / mdc-TJK) for Once-Monthly Schizophrenia Treatment. Medincell focuses on long-acting injectable treatments across therapeutic areas Schizophrenia Medincell Olanzapine NDA Teva Pharmaceuticals
BRIEF published on 11/11/2025 at 08:05, 10 months 4 days ago Medincell Expands Dr Grace Kim's Role to Boost US Capital Growth Biotechnology Medincell Pharmaceutical Strategy Dr Grace Kim US Capital Growth
BRIEF published on 11/11/2025 at 08:05, 10 months 4 days ago Medincell élargit le rôle du Dr Grace Kim pour stimuler la croissance du capital américain Biotechnologie Medincell Stratégie Pharmaceutique Dr Grace Kim Croissance Du Capital Américain
PRESS RELEASE published on 11/11/2025 at 08:00, 10 months 4 days ago Informations privilégiées / Autres communiqués Medincell nomme le Dr Grace Kim au poste de Chief Strategy Officer, U.S. Finance, pour renforcer la croissance de son capital aux États-Unis. Découvrez son parcours et son rôle clé chez Medincell Croissance Chief Strategy Officer Medincell Dr Grace Kim Capital Américain
PRESS RELEASE published on 11/11/2025 at 08:00, 10 months 4 days ago Inside Information / Other news releases Medincell appoints Dr. Grace Kim as Chief Strategy Officer, U.S. Finance to lead U.S. capital growth strategy. Medincell pioneers long-acting injectable therapies Medincell Dr. Grace Kim Long-acting Injectable Therapies U.S. Capital Growth Clinical-stage Pharmaceutical Company
BRIEF published on 11/05/2025 at 13:51, 10 months 10 days ago Croissance continue pour Medincell et nouvelles perspectives avec l'Olanzapine LAI Schizophrénie Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 11/05/2025 at 13:51, 10 months 10 days ago Continued growth for Medincell and new prospects with Olanzapine LAI Schizophrenia Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
PRESS RELEASE published on 11/05/2025 at 13:46, 10 months 10 days ago Inside Information / Other news releases Medincell's partner Teva plans US NDA submission for Olanzapine LAI in Q4 2025, while UZEDY® achieves continued growth in sales in Q3 2025 Medincell Teva Pharmaceuticals Olanzapine LAI US NDA Submission UZEDY Sales Growth
PRESS RELEASE published on 11/05/2025 at 13:46, 10 months 10 days ago Informations privilégiées / Autres communiqués Medincell annonce la poursuite de la croissance d'UZEDY® et la préparation du dépôt de l'Olanzapine LAI sur le marché américain par Teva Pharmaceuticals Croissance Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 10/10/2025 at 22:16, 11 months 4 days ago FDA Approves UZEDY for Bipolar I Disorder in Adults FDA Approval Mental Health Treatment UZEDY Bipolar I Disorder Risperidone
Published on 09/15/2026 at 17:00, 1 hour 9 minutes ago PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, Including 20.04 g/t Au over 0.85 m and 2251 g/t Ag With 3.0% Cu over 0.90 m
Published on 09/15/2026 at 16:35, 1 hour 34 minutes ago Innodata Appoints Admiral Michael S. Rogers, Former NSA Director and Commander of U.S. Cyber Command, to Its Board of Directors
Published on 09/15/2026 at 15:45, 2 hours 24 minutes ago Galaxy Ventures Inc. Announces Major Milestones for Qualifying Transaction: TruSilver Completes $2.5 Million Financing and Appoints Former IAMGOLD Chief Geologist Matt Rees as Director and Vice-President of Exploration
Published on 09/15/2026 at 15:35, 2 hours 34 minutes ago Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
Published on 09/15/2026 at 15:25, 2 hours 44 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
Published on 09/15/2026 at 17:57, 12 minutes ago BILENDI: Bilendi poursuit son développement en Allemagne : ouverture d’un nouveau bureau à Munich
Published on 09/15/2026 at 17:57, 12 minutes ago BILENDI: Bilendi expands its presence in Germany: Opening of a new office in Munich
Published on 09/15/2026 at 16:43, 1 hour 26 minutes ago DEAG: Bondholders approve amendment of the bond terms and conditions ("Notice of Results of a Written Resolution")
Published on 09/15/2026 at 16:10, 1 hour 59 minutes ago Duck Creek Closes Fiscal Year 2026 with Record Bookings as Insurers Accelerate Core Systems Modernization and Agentic AI Adoption
Published on 09/15/2026 at 16:05, 2 hours 4 minutes ago NOVVA Group secures landmark 3.17 GW renewable energy portfolio from ABO Energy to power global AI infrastructure
Published on 09/15/2026 at 18:00, 9 minutes ago Compte-rendu d’Assemblée Générale Mixte du 10 septembre 2026
Published on 09/15/2026 at 18:00, 9 minutes ago Report on the Combined General Meeting of the 10th of September 2026
